Data Archiving Permissions for JIG Authors
Responsible data sharing supports reproducibility in immunology and aging research.
Data Availability Expectations
Every manuscript must include a clear and practical data availability statement.
JIG encourages archiving of datasets, code, and protocols in recognized repositories where possible. Statements must define location, access terms, and any governance restrictions.
If data involve sensitive patient or age-related health information, provide controlled-access pathways with clear request criteria and contact mechanisms.
How to Choose a Suitable Archive
Repository quality affects long-term usability and compliance.
Trusted Repositories
Use platforms with stable governance and persistent access policies.
Persistent IDs
Provide DOI or accession identifiers for citable data linkage.
Governance Controls
Use managed-access systems for sensitive or restricted datasets.
Metadata Completeness
Add variable definitions, data dictionaries, and protocol context.
What to Include in Data Statements
Clear, specific statements reduce review delays and ambiguity.
Location
Name repository and provide persistent identifier link.
Access Terms
State open, embargoed, or controlled conditions.
Documentation
Reference codebooks and protocols required for interpretation.
Versioning
Specify dataset version used in the published analysis.
Statements should be concise but complete. Where access is restricted, include response expectations for data requests.
Data Stewardship and Reuse Governance
Clear permissions support reuse while protecting participants, institutions, and research integrity.
JIG supports responsible data sharing for immunology and geriatrics research by aligning archiving permissions with ethical obligations and legal requirements. Authors should state what data can be shared, under which conditions, and how external investigators may request access. Clear governance language improves trust and reduces ambiguity for secondary analysis teams.
When datasets include patient-level or potentially identifiable information, privacy safeguards must be explicit. Describe de-identification methods, access controls, and repository restrictions. If full open release is not possible, provide a controlled-access pathway with criteria for qualified use so valuable evidence remains discoverable and ethically reusable.
Permissions should be consistent across manuscript sections, supplementary files, and repository records. If a third-party dataset or licensed instrument is used, confirm redistribution rights before submission. Mismatched permissions are a common reason for post-acceptance corrections and can delay publication timelines.
For longitudinal aging studies, include retention policy and versioning strategy. Readers need to know whether data snapshots may change, how corrections are tracked, and which version supports reported results. Version transparency is especially important for multi-wave cohorts and registry-linked evidence in older populations.
Code availability should be addressed alongside data permissions. If analysis scripts are sharable, provide repository location and dependency details. If restrictions apply, explain the limitation and provide enough methodological information for review and replication assessment. Practical transparency often matters as much as full data release.
Questions about repository suitability, permission wording, or controlled-access statements can be directed to [email protected]. The editorial office can help authors align archive language with journal policy before final production checks.
When controlled access is required, specify the review authority, expected request timeline, and permitted analysis scope. Clear request mechanics help secondary researchers plan responsibly and reduce repeated correspondence. Transparent access criteria also demonstrate that restrictions are governance-based rather than arbitrary barriers to reuse.
For studies involving biobank assets or linked administrative data, include provenance notes and governance responsibilities for each data source. Detailed provenance improves interpretability, supports compliance review, and helps readers understand the context and constraints that shape reuse permissions.
Policy-quality publishing depends on consistency between manuscript content, metadata, and governance declarations. Authors and editors should treat discoverability, licensing, archiving, and integrity controls as connected systems rather than isolated tasks. When these components are aligned early, journals can process accepted papers more efficiently, improve repository compatibility, and strengthen confidence among readers, libraries, and indexing partners. JIG maintains this systems approach to support durable visibility and reliable scholarly records in immunology and geriatrics. Clear documentation at each stage, from submission to post-publication maintenance, reduces correction risk and protects the long-term value of published evidence.
Complete permission wording at first submission reduces production queries and accelerates compliant publication.
Early alignment on repository permissions protects publication timelines.
Publish With Reproducibility in Mind
JIG data archiving guidance supports transparency while respecting privacy constraints.
For support: [email protected]